Phase
Condition
N/ATreatment
2LEBV® / 2LXFS®
Placebo
Clinical Study ID
Ages > 12 All Genders
Study Summary
Eligibility Criteria
Inclusion
Pré-Inclusion Criteria:
Patients, male or female, aged 12 years and older,
Patient with fatigue for 1 month or more,
Patient with at least two other symptoms among the following: Long-lastingexhaustion even after light exertion, subfebrile state, fever, loss of appetite,nausea, angina, conjunctivis, sensitive cervical or axillary lymph nodes,erythematous and swollen tonsil, headaches, sore throat, myalgia, muscular weakness,arthralgia, splenomegaly, visual disorders, memory disorders, attention deficitdisorders, sleep disorders, gastrointestinal disorders, breathing disorders,cardiovascular disorders.
Patient (and/or parents if necessary) agrees to perform serology for the study,
Patient (and/or parents if necessary) agrees to perform lymphocyte typing for thestudy during the pre-inclusion visit,
Patients (and/or parents if necessary) having the faculties to understand andrespect the constraints of the study,
Signature of the Informed Consent Form by the patient (and/or parents if necessary).
Inclusion Criteria:
- Patient who have a positive serology for EBV (IgG and/or IgM positive).
Exclusion
Exclusion Criteria:
Patient who have received any treatment with the 2LEBV® or 2LXFS®,
Patients who have received any homeopathic treatment in the previous 2 months priorto the study,
Patients under immunosuppressive treatment,
Patient undergoing treatment for psychiatric disorders,
Patients having received immunotherapy or micro-immunotherapy during the last 3months,
Patients with known lactose intolerance,
Pregnant or breastfeeding women,
Patients who participated in a clinical study in the previous 2-months period,
Patients (and/or parents of patients if necessary) who are not sufficientlymotivated to engage on the total study follow-up period, or likely to travel or tomove before the end of the study,
Patients with severe immunodeficiency disease requiring long term treatment (*) orpatients under chemotherapy or radiotherapy,
Patients under homeopathic or phytotherapy treatment,
Patients addicted to or using recreational drugs,
Patient under guardianship and/or curatorship, (*) important renal or respiratoryinsufficiency, transplanted or grafted patients, HIV/AIDS, terminal cancer.
Study Design
Connect with a study center
Private Practice
Aartselaar, 2630
BelgiumActive - Recruiting
Private Practice
Boortmeerbeek, 3190
BelgiumTerminated
Private Practice
Brussels, 1040
BelgiumActive - Recruiting
Private practice
Brussels, 1040
BelgiumActive - Recruiting
Private Practice
Bruxelles, 1200
BelgiumActive - Recruiting
Private Practice
Gent, 9000
BelgiumActive - Recruiting
Private Practice
Jette, 1090
BelgiumSite Not Available
Private Practice
Limal, 1300
BelgiumSite Not Available
Private practice
Marche-en-Famenne, 6900
BelgiumActive - Recruiting
Private Practice
Nivelles, 1400
BelgiumSite Not Available
Cabinet privé
Schoten, 2900
BelgiumActive - Recruiting
Private practice
Stavelot, 4790
BelgiumActive - Recruiting
Private practice
Waregem, 8790
BelgiumActive - Recruiting
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.